Matches in Nanopublications for { <http://www.w3.org/1999/02/22-rdf-syntax-ns#OBJECT> ?p ?o ?g. }
- OBJECT label "to treat nasal type extranodal natural killer / T-cell lymphoma-associated hemophagocytic lymphohistiocytosis" provenance.
- OBJECT label "to treat nasal type extranodal natural killer / T-cell lymphoma-associated hemophagocytic lymphohistiocytosis" provenance.
- OBJECT label "to treat nasal type extranodal natural killer / T-cell lymphoma-associated hemophagocytic lymphohistiocytosis" provenance.
- OBJECT label "to treat nasal type extranodal natural killer / T-cell lymphoma-associated hemophagocytic lymphohistiocytosis" provenance.
- OBJECT label "to treat nasal type extranodal natural killer / T-cell lymphoma-associated hemophagocytic lymphohistiocytosis" provenance.
- OBJECT label "to treat nasal type extranodal natural killer / T-cell lymphoma-associated hemophagocytic lymphohistiocytosis" provenance.
- OBJECT label "to treat nasal type extranodal natural killer / T-cell lymphoma-associated hemophagocytic lymphohistiocytosis" provenance.
- OBJECT label "with increased Treg cells proliferation and expression of GATA-3 , IL-4 and IL-10" provenance.
- OBJECT label "with increased Treg cells proliferation and expression of GATA-3 , IL-4 and IL-10" provenance.
- OBJECT label "with increased Treg cells proliferation and expression of GATA-3 , IL-4 and IL-10" provenance.
- OBJECT label "with increased Treg cells proliferation and expression of GATA-3 , IL-4 and IL-10" provenance.
- OBJECT label "with increased Treg cells proliferation and expression of GATA-3 , IL-4 and IL-10" provenance.
- OBJECT label "with increased Treg cells proliferation and expression of GATA-3 , IL-4 and IL-10" provenance.
- OBJECT label "with increased Treg cells proliferation and expression of GATA-3 , IL-4 and IL-10" provenance.
- OBJECT label "with increased Treg cells proliferation and expression of GATA-3 , IL-4 and IL-10" provenance.
- OBJECT label "with increased Treg cells proliferation and expression of GATA-3 , IL-4 and IL-10" provenance.
- OBJECT label "with increased Treg cells proliferation and expression of GATA-3 , IL-4 and IL-10" provenance.
- OBJECT label "with increased Treg cells proliferation and expression of GATA-3 , IL-4 and IL-10" provenance.
- OBJECT label "with increased Treg cells proliferation and expression of GATA-3 , IL-4 and IL-10" provenance.
- OBJECT label "with increased Treg cells proliferation and expression of GATA-3 , IL-4 and IL-10" provenance.
- OBJECT label "with increased Treg cells proliferation and expression of GATA-3 , IL-4 and IL-10" provenance.
- OBJECT label "with increased Treg cells proliferation and expression of GATA-3 , IL-4 and IL-10" provenance.
- OBJECT label "with increased Treg cells proliferation and expression of GATA-3 , IL-4 and IL-10" provenance.
- OBJECT label "with increased Treg cells proliferation and expression of GATA-3 , IL-4 and IL-10" provenance.
- OBJECT label "with increased Treg cells proliferation and expression of GATA-3 , IL-4 and IL-10" provenance.
- OBJECT label "with increased Treg cells proliferation and expression of GATA-3 , IL-4 and IL-10" provenance.
- OBJECT label "with increased Treg cells proliferation and expression of GATA-3 , IL-4 and IL-10" provenance.
- OBJECT label "with increased Treg cells proliferation and expression of GATA-3 , IL-4 and IL-10" provenance.
- OBJECT label "with increased Treg cells proliferation and expression of GATA-3 , IL-4 and IL-10" provenance.
- OBJECT label "with increased Treg cells proliferation and expression of GATA-3 , IL-4 and IL-10" provenance.
- OBJECT label "with increased Treg cells proliferation and expression of GATA-3 , IL-4 and IL-10" provenance.
- OBJECT label "with increased Treg cells proliferation and expression of GATA-3 , IL-4 and IL-10" provenance.
- OBJECT label "with increased Treg cells proliferation and expression of GATA-3 , IL-4 and IL-10" provenance.
- OBJECT label "with increased Treg cells proliferation and expression of GATA-3 , IL-4 and IL-10" provenance.
- OBJECT label "with increased Treg cells proliferation and expression of GATA-3 , IL-4 and IL-10" provenance.
- OBJECT label "nasal type extranodal natural killer / T-cell lymphoma-associated hemophagocytic lymphohistiocytosis" provenance.
- OBJECT label "nasal type extranodal natural killer / T-cell lymphoma-associated hemophagocytic lymphohistiocytosis" provenance.
- OBJECT label "nasal type extranodal natural killer / T-cell lymphoma-associated hemophagocytic lymphohistiocytosis" provenance.
- OBJECT label "nasal type extranodal natural killer / T-cell lymphoma-associated hemophagocytic lymphohistiocytosis" provenance.
- OBJECT label "nasal type extranodal natural killer / T-cell lymphoma-associated hemophagocytic lymphohistiocytosis" provenance.
- OBJECT label "nasal type extranodal natural killer / T-cell lymphoma-associated hemophagocytic lymphohistiocytosis" provenance.
- OBJECT label "nasal type extranodal natural killer / T-cell lymphoma-associated hemophagocytic lymphohistiocytosis" provenance.
- OBJECT label "nasal type extranodal natural killer / T-cell lymphoma-associated hemophagocytic lymphohistiocytosis" provenance.
- OBJECT label "nasal type extranodal natural killer / T-cell lymphoma-associated hemophagocytic lymphohistiocytosis" provenance.
- OBJECT label "nasal type extranodal natural killer / T-cell lymphoma-associated hemophagocytic lymphohistiocytosis" provenance.
- OBJECT label "nasal type extranodal natural killer / T-cell lymphoma-associated hemophagocytic lymphohistiocytosis" provenance.
- OBJECT label "nasal type extranodal natural killer / T-cell lymphoma-associated hemophagocytic lymphohistiocytosis" provenance.
- OBJECT label "nasal type extranodal natural killer / T-cell lymphoma-associated hemophagocytic lymphohistiocytosis" provenance.
- OBJECT label "nasal type extranodal natural killer / T-cell lymphoma-associated hemophagocytic lymphohistiocytosis" provenance.
- OBJECT label "nasal type extranodal natural killer / T-cell lymphoma-associated hemophagocytic lymphohistiocytosis" provenance.
- OBJECT label "nasal type extranodal natural killer / T-cell lymphoma-associated hemophagocytic lymphohistiocytosis" provenance.
- OBJECT label "nasal type extranodal natural killer / T-cell lymphoma-associated hemophagocytic lymphohistiocytosis" provenance.
- OBJECT label "nasal type extranodal natural killer / T-cell lymphoma-associated hemophagocytic lymphohistiocytosis" provenance.
- OBJECT label "nasal type extranodal natural killer / T-cell lymphoma-associated hemophagocytic lymphohistiocytosis" provenance.
- OBJECT label "nasal type extranodal natural killer / T-cell lymphoma-associated hemophagocytic lymphohistiocytosis" provenance.
- OBJECT label "nasal type extranodal natural killer / T-cell lymphoma-associated hemophagocytic lymphohistiocytosis" provenance.
- OBJECT label "hemophagocytic lymphohistiocytosis ( NK)/T-LAHLH ), a rare and fatal disease with no effective therapy" provenance.
- OBJECT label "hemophagocytic lymphohistiocytosis ( NK)/T-LAHLH ), a rare and fatal disease with no effective therapy" provenance.
- OBJECT label "hemophagocytic lymphohistiocytosis ( NK)/T-LAHLH ), a rare and fatal disease with no effective therapy" provenance.
- OBJECT label "hemophagocytic lymphohistiocytosis ( NK)/T-LAHLH ), a rare and fatal disease with no effective therapy" provenance.
- OBJECT label "hemophagocytic lymphohistiocytosis ( NK)/T-LAHLH ), a rare and fatal disease with no effective therapy" provenance.
- OBJECT label "hemophagocytic lymphohistiocytosis ( NK)/T-LAHLH ), a rare and fatal disease with no effective therapy" provenance.
- OBJECT label "hemophagocytic lymphohistiocytosis ( NK)/T-LAHLH ), a rare and fatal disease with no effective therapy" provenance.
- OBJECT label "hemophagocytic lymphohistiocytosis ( NK)/T-LAHLH ), a rare and fatal disease with no effective therapy" provenance.
- OBJECT label "hemophagocytic lymphohistiocytosis ( NK)/T-LAHLH ), a rare and fatal disease with no effective therapy" provenance.
- OBJECT label "hemophagocytic lymphohistiocytosis ( NK)/T-LAHLH ), a rare and fatal disease with no effective therapy" provenance.
- OBJECT label "hemophagocytic lymphohistiocytosis ( NK)/T-LAHLH ), a rare and fatal disease with no effective therapy" provenance.
- OBJECT label "hemophagocytic lymphohistiocytosis ( NK)/T-LAHLH ), a rare and fatal disease with no effective therapy" provenance.
- OBJECT label "hemophagocytic lymphohistiocytosis ( NK)/T-LAHLH ), a rare and fatal disease with no effective therapy" provenance.
- OBJECT label "hemophagocytic lymphohistiocytosis ( NK)/T-LAHLH ), a rare and fatal disease with no effective therapy" provenance.
- OBJECT label "hemophagocytic lymphohistiocytosis ( NK)/T-LAHLH ), a rare and fatal disease with no effective therapy" provenance.
- OBJECT label "hemophagocytic lymphohistiocytosis ( NK)/T-LAHLH ), a rare and fatal disease with no effective therapy" provenance.
- OBJECT label "hemophagocytic lymphohistiocytosis ( NK)/T-LAHLH ), a rare and fatal disease with no effective therapy" provenance.
- OBJECT label "hemophagocytic lymphohistiocytosis ( NK)/T-LAHLH ), a rare and fatal disease with no effective therapy" provenance.
- OBJECT label "hemophagocytic lymphohistiocytosis ( NK)/T-LAHLH ), a rare and fatal disease with no effective therapy" provenance.
- OBJECT label "hemophagocytic lymphohistiocytosis ( NK)/T-LAHLH ), a rare and fatal disease with no effective therapy" provenance.
- OBJECT label "hemophagocytic lymphohistiocytosis ( NK)/T-LAHLH ), a rare and fatal disease with no effective therapy" provenance.
- OBJECT label "hemophagocytic lymphohistiocytosis ( NK)/T-LAHLH ), a rare and fatal disease with no effective therapy" provenance.
- OBJECT label "hemophagocytic lymphohistiocytosis ( NK)/T-LAHLH ), a rare and fatal disease with no effective therapy" provenance.
- OBJECT label "hemophagocytic lymphohistiocytosis ( NK)/T-LAHLH ), a rare and fatal disease with no effective therapy" provenance.
- OBJECT label "the critically ill pregnant woman suffering from chronic active hepatitis B combined with COVID-19" provenance.
- OBJECT label "the critically ill pregnant woman suffering from chronic active hepatitis B combined with COVID-19" provenance.
- OBJECT label "the critically ill pregnant woman suffering from chronic active hepatitis B combined with COVID-19" provenance.
- OBJECT label "the critically ill pregnant woman suffering from chronic active hepatitis B combined with COVID-19" provenance.
- OBJECT label "the critically ill pregnant woman suffering from chronic active hepatitis B combined with COVID-19" provenance.
- OBJECT label "the critically ill pregnant woman suffering from chronic active hepatitis B combined with COVID-19" provenance.
- OBJECT label "the critically ill pregnant woman suffering from chronic active hepatitis B combined with COVID-19" provenance.
- OBJECT label "the critically ill pregnant woman suffering from chronic active hepatitis B combined with COVID-19" provenance.
- OBJECT label "the critically ill pregnant woman suffering from chronic active hepatitis B combined with COVID-19" provenance.
- OBJECT label "the critically ill pregnant woman suffering from chronic active hepatitis B combined with COVID-19" provenance.
- OBJECT label "the critically ill pregnant woman suffering from chronic active hepatitis B combined with COVID-19" provenance.
- OBJECT label "the critically ill pregnant woman suffering from chronic active hepatitis B combined with COVID-19" provenance.
- OBJECT label "with good outcomes among select patients with newly diagnosed or stage I / II NK / T-LAHLH" provenance.
- OBJECT label "with good outcomes among select patients with newly diagnosed or stage I / II NK / T-LAHLH" provenance.
- OBJECT label "with good outcomes among select patients with newly diagnosed or stage I / II NK / T-LAHLH" provenance.
- OBJECT label "with good outcomes among select patients with newly diagnosed or stage I / II NK / T-LAHLH" provenance.
- OBJECT label "with good outcomes among select patients with newly diagnosed or stage I / II NK / T-LAHLH" provenance.
- OBJECT label "with good outcomes among select patients with newly diagnosed or stage I / II NK / T-LAHLH" provenance.
- OBJECT label "with good outcomes among select patients with newly diagnosed or stage I / II NK / T-LAHLH" provenance.
- OBJECT label "with good outcomes among select patients with newly diagnosed or stage I / II NK / T-LAHLH" provenance.